Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Harvard Business School
Cipla
Express Scripts
Cantor Fitzgerald
Julphar
Merck
Argus Health
Medtronic

Generated: June 21, 2018

DrugPatentWatch Database Preview

TOLINASE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Tolinase patents expire, and what generic alternatives are available?

Tolinase is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in TOLINASE is tolazamide. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the tolazamide profile page.
Summary for TOLINASE
Drug patent expirations by year for TOLINASE
Medical Subject Heading (MeSH) Categories for TOLINASE
Synonyms for TOLINASE
(azaperhydroepinylamino)-N-[(4-methylphenyl)sulfonyl]carboxamide
1-(((((4-Methylphenyl)sulfonyl)amino)carbonyl)amino)azepane
1-(azepan-1-yl)-3-(4-methylbenzenesulfonyl)urea
1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea
1-(azepan-1-yl)-3-(p-tolylsulfonyl)urea
1-(azepan-1-yl)-3-[(4-methylbenzene)sulfonyl]urea
1-(Hexahydro-1-azepinyl)-3-p-tolylsulfonylurea
1-(Hexahydro-1H-azepin-1-yl)-3-(p-toluenesulfonyl)urea
1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea
1-[(([(4-Methylphenyl)sulfonyl]amino)carbonyl)amino]azepane #
1156-19-0
2761AH
3-azepan-1-yl-1-(4-methylphenyl)sulfonyl-urea
4-(p-Tolylsulfonyl)-1,1-hexamethylene
4-(p-Tolylsulfonyl)-1,1-hexamethylenesemicarbazide
5-20-04-00062 (Beilstein Handbook Reference)
59866P
9LT1BRO48Q
AB00052247
AB00052247_16
AB00052247_17
AB00052247-15
AC1L1KHJ
ACN-053046
AI3-50826
AKOS015913823
API0004439
BCBcMAP01_000061
Benzenesulfonamide, {N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-}
Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methyl-
Benzenesulfonamide, N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methyl-
Benzenesulfonamide, N-[[(hexahydro-1-azepinyl)amino]carbonyl]-4-methyl-
Benzenesulfonamide, N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-
Bio1_000204
Bio1_000693
Bio1_001182
Bio2_000225
Bio2_000705
BPBio1_000691
BRD-K32164935-001-06-8
BRN 1323565
BSPBio_000627
BSPBio_001505
BSPBio_003025
C-55259
C14H21N3O3S
CAS-1156-19-0
CBiol_001918
CCG-39178
CCRIS 591
CHEBI:9613
CHEMBL817
CPD000058290
D00379
D09FJB
DB00839
Diabewas
DivK1c_000212
DSSTox_CID_1358
DSSTox_GSID_21358
DSSTox_RID_76105
DTXSID3021358
EINECS 214-588-3
EU-0101195
F2173-1137
FT-0675268
GP6227
GTPL6847
HE021347
HE298602
HMS1361L07
HMS1569P09
HMS1791L07
HMS1921P19
HMS1989L07
HMS2089L10
HMS2092L09
HMS2096P09
HMS2232L21
HMS3259O18
HMS3263P11
HMS3369L04
HMS3402L07
HMS500K14
HSDB 3192
HY-B0920
I14-44488
IDI1_000212
IDI1_033975
KBio1_000212
KBio2_000225
KBio2_001749
KBio2_002793
KBio2_004317
KBio2_005361
KBio2_006885
KBio3_000449
KBio3_000450
KBio3_002525
KBioGR_000225
KBioGR_000939
KBioSS_000225
KBioSS_001749
KS-1438
Lopac-T-2408
Lopac0_001195
LP01195
LS-578
MCULE-9265102499
MFCD00083504
MLS000028534
MLS001076161
MolPort-001-826-273
N-(((Hexahydro-1H-azepin-1-yl)-amino)carbonyl)-4-methylbenzenesulfonamide
N-(((hexahydro-1H-azepin-1-yl)amino)carbonyl)-4-methylbenzenesulfonamide
N-(azepan-1-ylcarbamoyl)-4-methylbenzenesulfonamide
N-(p-Toluenesulfonyl)-N'-hexamethyleniminourea
N-[(azepan-1-ylamino)carbonyl]-4-methylbenzenesulfonamide
N-[[(Hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methylbenzenesulfonamide
N-{[(hexahydro-1H-azepin-1-yl)-amino]carbonyl}-4-methylbenzenesulfonamide
NC00590
NCGC00016009-01
NCGC00016009-02
NCGC00016009-03
NCGC00016009-04
NCGC00016009-05
NCGC00016009-06
NCGC00016009-07
NCGC00016009-08
NCGC00016009-09
NCGC00016009-10
NCGC00016009-11
NCGC00016009-12
NCGC00016009-13
NCGC00016009-14
NCGC00016009-15
NCGC00016009-16
NCGC00016009-17
NCGC00016009-19
NCGC00023701-03
NCGC00023701-04
NCGC00023701-05
NCGC00023701-06
NCGC00023701-07
NCGC00023701-08
NCGC00023701-09
NCGC00023701-10
NCGC00254501-01
NCGC00259058-01
NCGC00261880-01
NCI-C03327
NCIOpen2_008361
NINDS_000212
Norglycin
NSC 70762
NSC-70762
NSC-758149
NSC70762
NSC758149
Opera_ID_1740
Oprea1_061180
OUDSBRTVNLOZBN-UHFFFAOYSA-N
Pharmacia Brand of Tolazamide
Pharmakon1600-01501201
Prestwick_865
Prestwick0_000554
Prestwick1_000554
Prestwick2_000554
Prestwick3_000554
Ronase
SAM002564236
SBB058190
SBI-0051162.P003
SCHEMBL34417
SMR000058290
SPBio_001317
SPBio_002548
Spectrum_001269
SPECTRUM1501201
Spectrum2_001449
Spectrum3_001473
Spectrum4_000240
Spectrum5_001204
SR-01000003105
SR-01000003105-2
SR-01000003105-4
ST51015133
T 2408
Tolamide
Tolanase
Tolazamid
Tolazamida
Tolazamida [INN-Spanish]
tolazamide
Tolazamide (JP15/USP/INN)
Tolazamide (JP17/USP/INN)
Tolazamide [USAN:INN:BAN:JAN]
Tolazamide [USAN:USP:INN:BAN:JAN]
Tolazamide, United States Pharmacopeia (USP) Reference Standard
Tolazamidum
Tolazamidum [INN-Latin]
Tolazolamide
Tolinase (TN)
Tox21_110281
Tox21_110281_1
Tox21_201507
Tox21_300416
Tox21_501195
U 17835
U-17835
UNII-9LT1BRO48Q
Urea, 1-(hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)-
Urea, 1-(hexahydroazepin-1-yl)-3-p-tolylsulfonyl-
W-109110
WLN: T7NTJ AMVMSWR D1
ZINC57512

US Patents and Regulatory Information for TOLINASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn TOLINASE tolazamide TABLET;ORAL 015500-005 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Baxter
Dow
Moodys
AstraZeneca
Daiichi Sankyo
Citi
Express Scripts
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.